modifier

(redirected from biomodulator)
Also found in: Dictionary, Thesaurus, Medical.

modifier

Modifiers are, quite simply, any word or group of words that modifies (describes or elaborates upon) another element in a sentence. Modifiers can either be adjectives, which modify nouns (or sometimes pronouns), or adverbs, which modify pretty much everything else (usually verbs, adjectives, and other adverbs). Whether a modifier is an adjective or adverb depends on what it modifies and how it functions in a sentence.
Continue reading...

modifier

[′mäd·ə‚fī·ər]
(computer science)
A quantity used to alter the address of an operand in a computer, such as the cycle index. Also known as index word.
(materials)
In flotation, any of the chemicals which increase the specific attraction between collector agents and particle surfaces or which increase the wettability of those surfaces.

Modifier

A method to influence color, transparency, surface normals, or light emission, depending on the type of modifier and the type of material. Modifiers can be combined, so that each modifier in the chain influences a specific property of the material.

modifier

(programming)
An operation that alters the state of an object. Modifiers often have names that begin with "set" and corresponding selector functions whose names begin with "get".
References in periodicals archive ?
In 2004, Texas-based Jerry Tennant, MD, developed an easier-to-use, more effective version of the Russian invention, powered by two AA batteries, called the Tennant Biomodulator.
CoFactor is a folate-based biomodulator drug designed to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapeutic agent 5-FU.
CoFactor is ADVENTRX's biomodulator designed to enhance the activity of the widely used cancer drug 5-fluorouracil (5-FU).
CoFactor (ANX-510) is a folate-based biomodulator drug designed to replace leucovorin to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapy 5-fluorouracil (5-FU).
This will be the Company's first presentation of results demonstrating enhancement of UFT antitumor activity using its 5-FU biomodulator, CoFactor.
CoFactor (ANX-510) is a folate-based biomodulator drug designed to replace leucovorin as the preferred method to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapy 5-fluorouracil (5-FU).
ANX-510 is a folate-based biomodulator drug designed to replace leucovorin as the preferred method to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapy 5-fluorouracil (5-FU).